Previous 10 | Next 10 |
Company's proprietary AI technology allows for expansion into predictive monitoring and new disease profiling The New England Journal of Medicine article cites AI and its potential for increased healthcare efficiency and insights REDWOOD CITY, CA / ACCESSWIRE / May 23, 2023 / Dr. Waqaas...
2023-05-16 10:23:33 ET Consumer healthcare technology company Biotricity ( NASDAQ: BTCY ) said on Tuesday that its April annualized revenue run rate reached $13M, compared to the $12M run rate for March. The company anticipates continued topline revenue growth, along with cont...
Corporate Impact Report concluded better patient outcomes and substantial cost savings for patients using Company's devices REDWOOD CITY, CA / ACCESSWIRE / May 16, 2023 / Biotricity Inc. (NASDAQ:BTCY) ("Biotricity" or the "Company"), a leading medical diagnostic and consumer healthcar...
Dr. Waqaas will address, meet with, world leaders and medical innovators on pressing challenges and solutions in global cardiovascular health, digital health and AI REDWOOD CITY, CA / ACCESSWIRE / May 10, 2023 / Biotricity Inc. (NASDAQ:BTCY) ("Biotricity" or the "Company"), a leading med...
REDWOOD CITY, CA / ACCESSWIRE / April 21, 2023 / Biotricity Inc. (NASDAQ:BTCY), a medical technology company committed to improving healthcare by developing solutions that aid in chronic disease prevention and management, is taking action to tackle the unmet need in cardiovascular diseases (CV...
2023-04-19 09:40:15 ET Biotricity ( NASDAQ: BTCY ) reached a record $12M annualized revenue run rate in March 2023. The company attributed its strengthening financials to the growing sales of its product line of remote cardiac monitors spanning consumers to cardiologists, ...
REDWOOD CITY, CA / ACCESSWIRE / April 19, 2023 / Biotricity Inc. (NASDAQ:BTCY) ("Biotricity" or the "Company"), a leading medical diagnostic and consumer healthcare technology company, today reported that it reached a record $12 million annualized revenue run rate in March 2023. Based on prel...
"Inducing Better Patient Outcomes, Substantial Cost Savings" REDWOOD CITY, CA / ACCESSWIRE / April 11, 2023 / Biotricity, Inc. (NASDAQ:BTCY) ("Biotricity" or the "Company"), a leading medical diagnostic and consumer healthcare technology company, has released its first Corporate Impact Rep...
Highlights Several Major Operating Milestones Since FY22 REDWOOD CITY, CA / ACCESSWIRE / March 7, 2023 / Biotricity, Inc. (Nasdaq:BTCY) ("Biotricity" or the "Company"), a medical diagnostic and consumer healthcare technology company, has not only been establishing a significant market foot...
Biotricity, Inc. (BTCY) Q3 2023 Earnings Conference Call February 14, 2023, 04:30 PM ET Company Participants Debra Chen - Investor Relations Waqaas Al-Siddiq - Founder & Chief Executive Officer John Ayanoglou - Chief Financial Officer Conference Call Particip...
News, Short Squeeze, Breakout and More Instantly...
REDWOOD CITY, CA / ACCESSWIRE / July 22, 2024 / Biotricity Inc. (Nasdaq:BTCY), a Technology-as-a-Service (TaaS) company operating in the remote cardiac monitor sector of consumer healthcare, today announced ongoing improvements in operational efficiency, scalability and margin performance driven...
ORLANDO, FL / ACCESSWIRE / July 19, 2024 / RedChip Companies will air interviews with Enlivex Therapeutics Ltd. (Nasdaq:ENLV) and Biotricity, Inc. (Nasdaq:BTCY) on the RedChip Small Stocks, Big Money™ show, a sponsored program on Bloomberg TV, this Saturday, July 20, at 7 p.m. Eastern T...
ORLANDO, FL / ACCESSWIRE / July 12, 2024 / RedChip Companies will air interviews with Biotricity, Inc. (Nasdaq:BTCY) and bioAffinity Technologies, Inc. (Nasdaq:BIAF) on the RedChip Small Stocks, Big Money™ show, a sponsored program on Bloomberg TV, this Saturday, July 13, at 7 p.m. East...